Akums Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE09XN01023
  • NSEID: AKUMS
  • BSEID: 544222
INR
696.50
34.05 (5.14%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 6.61 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,166.63
1,157.87
1,159.59
1,017.53
1,024.03
1,055.55
1,010.41
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,166.63
1,157.87
1,159.59
1,017.53
1,024.03
1,055.55
1,010.41
Raw Material Cost
682.12
586.91
611.26
552.63
547.90
623.85
564.60
Purchase of Finished goods
26.49
62.93
60.29
56.71
21.08
19.49
30.27
(Increase) / Decrease In Stocks
-63.19
10.63
7.04
-16.77
12.94
-4.25
7.52
Employee Cost
201.43
199.03
189.38
189.27
176.14
183.90
175.60
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
-0.01
-0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
145.10
146.66
144.77
141.23
137.00
138.64
111.06
Total Expenditure (Excl Depreciation)
991.95
1,006.15
1,012.73
923.06
895.06
961.63
889.05
Operating Profit (PBDIT) excl Other Income
174.68
151.72
146.86
94.47
128.97
93.92
121.36
Other Income
30.38
35.30
34.33
32.37
26.73
17.55
14.56
Operating Profit (PBDIT)
205.06
187.02
181.19
126.84
155.70
111.47
135.92
Interest
24.76
23.89
23.74
23.30
23.14
4.54
5.13
Exceptional Items
0.00
-1.80
-18.23
0.00
0.00
8.22
4.78
Gross Profit (PBDT)
180.30
161.33
139.22
103.54
132.56
115.15
135.57
Depreciation
41.07
40.12
39.65
37.86
36.92
40.00
44.52
Profit Before Tax
139.24
121.22
99.57
65.67
95.65
75.14
91.05
Tax
38.26
39.87
31.89
22.98
30.96
-74.47
24.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
100.98
81.34
67.67
42.70
64.69
149.61
66.31
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
100.98
81.34
67.67
42.70
64.69
149.61
66.31
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.97
-3.27
1.36
1.91
1.21
1.99
1.13
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
100.01
84.61
66.32
40.78
63.48
147.62
65.18
Equity Capital
30.62
30.62
30.62
30.62
30.62
30.62
30.62
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
6.53
5.53
4.33
2.66
4.15
9.64
4.26
Diluted Earnings per share
6.53
5.53
4.33
2.66
4.15
9.64
4.26
Operating Profit Margin (Excl OI)
14.97%
13.1%
12.66%
9.28%
12.59%
8.9%
12.01%
Gross Profit Margin
15.45%
13.93%
12.01%
10.18%
12.94%
10.91%
13.42%
PAT Margin
8.66%
7.02%
5.84%
4.2%
6.32%
14.17%
6.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.76% vs -0.15% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 18.20% vs 27.58% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 15.13% vs 3.31% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 3.64% vs 0.63% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Akums Drugs With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,166.63
0
1,166.63
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,166.63
0
1,166.63
Raw Material Cost
682.12
0
682.12
Purchase of Finished goods
26.49
0
26.49
(Increase) / Decrease In Stocks
-63.19
0
-63.19
Employee Cost
201.43
0
201.43
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
145.10
0.00
145.10
Total Expenditure (Excl Depreciation)
991.95
0
991.95
Operating Profit (PBDIT) excl Other Income
174.68
0.00
174.68
Other Income
30.38
0
30.38
Operating Profit (PBDIT)
205.06
0
205.06
Interest
24.76
0
24.76
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
180.30
0
180.30
Depreciation
41.07
0
41.07
Profit Before Tax
139.24
0
139.24
Tax
38.26
0
38.26
Provisions and contingencies
0.00
0
0.00
Profit After Tax
100.98
0
100.98
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
100.98
0
100.98
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.97
0
0.97
Other related items
0.00
0.00
0.00
Consolidated Net Profit
100.01
0
100.01
Equity Capital
30.62
0
30.62
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
6.53
0
6.53
Diluted Earnings per share
6.53
0
6.53
Operating Profit Margin (Excl OI)
14.97%
0%
0.00
14.97%
Gross Profit Margin
15.45%
0%
0.00
15.45%
PAT Margin
8.66%
0%
0.00
8.66%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,166.63 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.76% vs -0.15% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 13.93% vs 0.48% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 100.01 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 18.20% vs 27.58% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 57.55% vs 5.50% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 174.68 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 15.13% vs 3.31% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 35.44% vs 0.75% in Jun 2025

Quarterly - Interest
Interest 24.76 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 3.64% vs 0.63% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 7.00% vs 77.73% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.97%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025